SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹211 Cr | ₹168 Cr | ₹69 Cr | ₹62 Cr | ₹28 Cr |
What is the latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹211 Cr |
| Mar2024 | ₹168 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹62 Cr |
| Mar2017 | ₹28 Cr |
How is Net Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹211 Cr | 25.20 | |
| Mar2024 | ₹168 Cr | 145.53 | |
| Mar2023 | ₹69 Cr | 11.35 | |
| Mar2022 | ₹62 Cr | 122.16 | |
| Mar2017 | ₹28 Cr | - | |
Compare Net Current Assets of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,290.6 Cr | -3.2% | -4.2% | -27.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3.2% |
-4.2% |
-27.5% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses